Form 4: Dolby Laboratories Director Emily Rollins Reports Stock Sale

Director Emily Rollins sold 1,000 shares of Dolby Laboratories Class A Common Stock at $80.88 per share on March 1, 2024, according to a Form 4 filing.

Summary

• On March 1, 2024, Emily Rollins, a director of Dolby Laboratories, Inc., sold 1,000 shares of Class A Common Stock.
• The sale price was $80.88 per share.
• Following the transaction, Rollins directly owns 7,493 shares of Class A Common Stock, including 2,952 shares underlying restricted stock units that are subject to vesting.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on February 8, 2023.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.

Industry Context

Form 4 filings are standard disclosures required by the SEC when insiders (directors, officers, or those holding more than 10% of a company's shares) buy or sell their company's stock. These filings provide transparency into insider transactions and can be used by investors to gauge sentiment and potential future stock performance.

Stakeholder Impact

• The stock sale by a director could be perceived neutrally or slightly negatively by shareholders, depending on the context and reasons behind the sale.

Key Dates